Intelligo

Norwegian-registered foreign company · Oslo

ASTELLAS PHARMA NUF

ActiveActivities of agents involved in the wholesale of other particular products (46.180)

Chief executive
Mark Andree Dekker
Business address
C. J. Hambros plass 2, 0164 Oslo

The life line 2025–2026

Operating revenue per year, with recorded events above. As a table

Operating revenue 2026: NOK 21.7m.

  1. Managing director took office§ 07
  2. Founded§ 16

Sources: the Register of Company Accounts (company accounts), fetched 1 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.

In brief

ASTELLAS PHARMA NUF is a norwegian-registered foreign company in Oslo, in the industry activities of agents involved in the wholesale of other particular products. The chief executive is Mark Andree Dekker. In 2026 the company had NOK 21.7m in operating revenue and a net profit of NOK −1.7m.

Put together by Intelligo from the sections below; each figure stands with its source where it belongs.

Overview

§ 01 Latest changes

4 changes, latest 16 Oct 2026

  • Annual accounts filed 2025 → 2026
  • Godkjent årsregnskap
  • Endring av daglig leder
  • Endring av forretningsadresse

Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →

Overview

§ 02 Worth knowing

None registered

None of the rules apply.The rules are fixed: bankruptcy, missing annual accounts, three years of losses, negative equity and the like. Checked 15 Nov 2026.

Overview

§ 03 Key figures

Revenue NOK 21.7m in 2026

Revenue

NOK 21.7m

−37.2% from 2025

20242026

Operating profit

NOK −2.1m

−255.9% from 2025

20242026

Net profit

NOK −1.7m

−277.8% from 2025

20242026

Equity

—

— from 2025

20242026

Source: the Register of Company Accounts, read 1 Nov 2026 · The full accounts →

Finances

§ 04 Where the money comes from and goes

Financial year 2026

Of every krone of operating revenue in 2026:

  • Operating costs 110%

Costs exceeded revenue: the operating result was NOK −2.1m.

Source: the Register of Company Accounts, read 1 Nov 2026

Finances

§ 05 Financial health

Financial year 2026

RevenueNOK 21.7m Operating margin−9.8% Revenue growth−37.2%
  • ASTELLAS PHARMA NUF, 2026
  • Industry median, assumed: NOK 52.8m · 4.8% · −0.4%

Source: the Register of Company Accounts, read 1 Nov 2026. The median is derived by Intelligo from 165 companies in industry division 46 (Wholesale trade), not stated by the source.

Finances

§ 06 Accounts

2 years, latest 2026

NOK 1,0002025–2620262025
Operating revenue21,69134,545
Operating profit−2,1281,365
Profit before tax−1,9141,578
Net profit−1,744981
Total assets7,5588,071
Equity—0
Liabilities7,5588,071

Source: the Register of Company Accounts, read 1 Nov 2026 · All 2 years →

Management and ownership

§ 07 Officers

5 officers now

Source: the Brønnøysund Register Centre, read 23 Oct 2026 · All 5 roles, former ones too →

Management and ownership

§ 08 Signature, procuration and authorisations

None registered

No signature or procuration registered.The Register of Business Enterprises has no provision for the company. Checked 15 Nov 2026.

Management and ownership

§ 09 Owners

None registered

No owners registered.The Tax Administration's shareholder register covers limited companies and has no owners for this business. Checked 15 Nov 2026.

Management and ownership

§ 10 Group

None registered

Not a group.No subsidiaries in the shareholder register, and no group accounts. Checked 15 Nov 2026.

Management and ownership

§ 11 Portfolio

None registered

No holdings registered.The shareholder register has no shares held by the company. Checked 15 Nov 2026.

Management and ownership

§ 12 Network

None registered

No connections.Nobody with a role here has roles in other companies. Checked 15 Nov 2026.

Events and registers

§ 13 Events

27 since 2015

Events per year

20152026

  • Notices39
  • Register changes1
  • Tenders won1

Since 2015: 39 announcements, 1 register change and 1 tender won. Most happened in 2015 and 2025.

Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 1 Nov 2026. Register changes are Intelligo's own observations. · All 27 events →

Events and registers

§ 14 Notices

39, latest 15 Oct 2026

  • Godkjente årsregnskap
  • Daglig leder
  • Forretningsadresse

Source: The Brønnøysund Register Centre's announcements ↗, read 1 Nov 2026 · All 39 →

Events and registers

§ 15 Charges

Not fetched yet

Events and registers

§ 16 Other registers

Found in 3 of 7

  • The Central Coordinating RegisterRegistered 20 Feb 1995
  • VATRegistered
  • The Register of Business EnterprisesRegistered 6 Jan 1994
  • The Cleaning RegisterNot registered
  • The Register of Staffing AgenciesNot registered
  • Smiley scheme, the Norwegian Food Safety AuthorityNot registered
  • The Financial Supervisory Authority's licence registerNot registered

Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026

Market

§ 17 Tenders

1 tender

  • 2025
  • Won
  • Lost
AwardedContractBuyerOutcome
May 2025Intensjonskunngjøring: Avtale Xtandi (enzalutamid)SYKEHUSINNKJØP HFWon

Source: Doffin and TED, read 10 Jul 2026. · All 1 tenders →

Market

§ 18 Vacancies

None registered

No vacancies.No open ads at NAV. Checked 15 Nov 2026.

Market

§ 19 Competitors

Industry code 46.180

The companies most like it:

Compare them

The selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →

Last

§ 20 Questions and answers

4 questions

  • Who is the chief executive of ASTELLAS PHARMA NUF?
    Mark Andree Dekker, since 2025. § 07
  • What was the revenue in 2026?
    NOK 21.7m in the company. § 06
  • Who is the auditor?
    ERNST & YOUNG AS. § 07
  • Where is ASTELLAS PHARMA NUF based?
    C. J. Hambros plass 2, 0164 Oslo.

The answers come from the sections linked to, with their sources.

01Latest changesOverviewContentsClose